Additionally, colon cancer patients with COVID-19 have been reported to exhibit more severe symptoms, such as lymphopenia, elevated respiratory rates, and increased hypersensitive C-reactive protein levels, compared to COVID-19 patients without cancer31,32. This evidence concerns the gene CRP and COVID-19.